Europe · Agences & temps réel · ANP

SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopli

Publié par ANP · Pays-Bas il y a 20 h

Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with MagicTouch PTA, ...

Lire l'article complet sur ANP Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (persportaal.anp.nl)

SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopli

À lire aussi

Former Mercedes-Benz plant in Moscow Region to start operations in Q1 2027

Bitcoin hits investors with 7.4% drop in October following Binance cyberattack

Fabricante de componentes automóvel Schaffler vai cortar 3.460 postos de trabalho

Trading Day: Oil slump no cure for AI angst

Fastmarkets clarifies China domestic steel scrap methodology guide

Merz says Germany must preserve 'digital sovereignty' in AI era

SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopli

Partager

À lire aussi

Former Mercedes-Benz plant in Moscow Region to start operations in Q1 2027

Bitcoin hits investors with 7.4% drop in October following Binance cyberattack

Fabricante de componentes automóvel Schaffler vai cortar 3.460 postos de trabalho

Trading Day: Oil slump no cure for AI angst

Fastmarkets clarifies China domestic steel scrap methodology guide

Merz says Germany must preserve 'digital sovereignty' in AI era